Ledger.Open graph →
SEC Form D · filed September 24, 2021

Garuda Therapeutics, Inc

Offering
$71.8M
Sold
$48.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NATICK, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Carl I. Gordon · Natick, MADirectorRahul I. Singhvi · Natick, MADirectorEric I. Aguiar · Natick, MADirectorShaan I. Gandhi · Natick, MADirectorDhvanit I. Shah · Natick, MAExec · DirectorRahul I. Singhvi · Natick, MADirectorEric I. Aguiar · Natick, MADirectorShaan I. Gandhi · Natick, MADirectorDhvanit I. Shah · Natick, MAExec · DirectorCarl I. Gordon · Natick, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗